Skip to content
10-Q

Quarterly Report

Biostar Pharmaceuticals, Inc.

0001185185-17-002396

← back to feed
Filed
Nov 15, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Nov 15, 2017 2.64M sh
Shares Diluted Q2 2017 · Jun 30, 2017 2.64M sh
Shares Diluted Q2 2017 · Jun 30, 2017 2.64M sh
Shares Diluted Q2 2017 · Jun 30, 2016 2.21M sh
Shares Diluted Q2 2017 · Jun 30, 2016 2.21M sh
Capex Q2 2017 · Jun 30, 2017 $4.36M
Capex Q2 2017 · Jun 30, 2016 $0
Operating Cash Flow Q2 2017 · Jun 30, 2017 $4.59M
Operating Cash Flow Q2 2017 · Jun 30, 2016 $353.63K
Short Term Debt Q2 2017 · Jun 30, 2017 $2.38M
Short Term Debt Q2 2017 · Jun 30, 2017 ¥20M
Short Term Debt Q2 2017 · Dec 31, 2016 $2.33M
Short Term Debt Q2 2017 · Dec 31, 2016 ¥20M
Cash And Equivalents Q2 2017 · Jun 30, 2017 $407.41K
Cash And Equivalents Q2 2017 · Dec 31, 2016 $173.29K
Cash And Equivalents Q2 2017 · Jun 30, 2016 $207.11K
Cash And Equivalents Q2 2017 · Dec 31, 2015 $38.9K
Stockholders Equity Q2 2017 · Jun 30, 2017 $35.49M
Stockholders Equity Q2 2017 · Dec 31, 2016 $36.88M
Current Liabilities Q2 2017 · Jun 30, 2017 $5.29M
Current Liabilities Q2 2017 · Dec 31, 2016 $5.62M
Current Assets Q2 2017 · Jun 30, 2017 $891.13K
Current Assets Q2 2017 · Dec 31, 2016 $7.37M
Total Assets Q2 2017 · Jun 30, 2017 $40.78M
Total Assets Q2 2017 · Dec 31, 2016 $42.5M
Eps Diluted Q2 2017 · Jun 30, 2017 −$0.50
Eps Diluted Q2 2017 · Jun 30, 2017 −$0.88
Eps Diluted Q2 2017 · Jun 30, 2016 −$3.12
Eps Diluted Q2 2017 · Jun 30, 2016 −$3.40
Eps Basic Q2 2017 · Jun 30, 2017 −$0.50
Eps Basic Q2 2017 · Jun 30, 2017 −$0.88
Eps Basic Q2 2017 · Jun 30, 2016 −$3.12
Eps Basic Q2 2017 · Jun 30, 2016 −$3.40
Sga Expense Q2 2017 · Jun 30, 2017 $1.52M
Sga Expense Q2 2017 · Jun 30, 2017 $2.28M
Sga Expense Q2 2017 · Jun 30, 2016 $539.43K
Sga Expense Q2 2017 · Jun 30, 2016 $1.23M
Net Income Q2 2017 · Jun 30, 2017 −$1.31M
Net Income Q2 2017 · Jun 30, 2017 −$2.33M
Net Income Q2 2017 · Jun 30, 2016 −$6.9M
Net Income Q2 2017 · Jun 30, 2016 −$7.52M
Operating Income Q2 2017 · Jun 30, 2017 −$1.53M
Operating Income Q2 2017 · Jun 30, 2017 −$2.57M
Operating Income Q2 2017 · Jun 30, 2016 −$6.86M
Operating Income Q2 2017 · Jun 30, 2016 −$7.53M
Gross Profit Q2 2017 · Jun 30, 2017 $0
Gross Profit Q2 2017 · Jun 30, 2017 $0
Gross Profit Q2 2017 · Jun 30, 2016 $298.89K
Gross Profit Q2 2017 · Jun 30, 2016 $643.86K
Cost Of Revenue Q2 2017 · Jun 30, 2017 $0
Cost Of Revenue Q2 2017 · Jun 30, 2017 $0
Cost Of Revenue Q2 2017 · Jun 30, 2016 $321.25K
Cost Of Revenue Q2 2017 · Jun 30, 2016 $777.91K
Revenue Q2 2017 · Jun 30, 2017 $0
Revenue Q2 2017 · Jun 30, 2017 $0
Revenue Q2 2017 · Jun 30, 2016 $620.14K
Revenue Q2 2017 · Jun 30, 2016 $1.42M